Bill > SB0616

This bill amends the Opioid Liability Litigation Act to expand the list of opioid-related settlements that limit legal actions by political subdivisions in Michigan. The bill adds several new settlements to the existing law, including settlements with pharmaceutical companies like Alvogen, Amneal, Apotex, Hikma, Indivior, Kroger, Mylan, Sun, and Zydus. The bill updates the definitions section to include these new settlements, which arose from a multidistrict litigation (MDL) in federal court related to prescription opioid litigation. The key provision prohibits political subdivisions (such as counties, cities, townships, and school districts) from filing lawsuits related to these settlements after specific dates, with most new settlements prohibiting legal actions after January 1, 2025. The bill also includes a specific provision for the Purdue Pharma settlement, which prevents legal actions related to shareholder claims after January 1, 2025. This legislation continues Michigan's efforts to resolve opioid-related litigation through comprehensive settlement agreements with various pharmaceutical companies and distributors involved in the opioid crisis.